These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 29635894)
1. Pterostilbene inhibits MTA1/HDAC1 complex leading to PTEN acetylation in hepatocellular carcinoma. Qian YY; Liu ZS; Yan HJ; Yuan YF; Levenson AS; Li K Biomed Pharmacother; 2018 May; 101():852-859. PubMed ID: 29635894 [TBL] [Abstract][Full Text] [Related]
2. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Dhar S; Kumar A; Li K; Tzivion G; Levenson AS Biochim Biophys Acta; 2015 Feb; 1853(2):265-75. PubMed ID: 25447541 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. Kai L; Samuel SK; Levenson AS Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103 [TBL] [Abstract][Full Text] [Related]
4. Pterostilbene increases PTEN expression through the targeted downregulation of microRNA-19a in hepatocellular carcinoma. Qian YY; Liu ZS; Zhang Z; Levenson AS; Li K Mol Med Rep; 2018 Apr; 17(4):5193-5201. PubMed ID: 29393488 [TBL] [Abstract][Full Text] [Related]
5. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression. Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573 [TBL] [Abstract][Full Text] [Related]
6. Tumoricidal activities of pterostilbene depend upon destabilizing the MTA1-NuRD complex and enhancing P53 acetylation in hepatocellular carcinoma. Qian YY; Liu ZS; Pan DY; Li K Exp Ther Med; 2017 Oct; 14(4):3098-3104. PubMed ID: 29042910 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Yoo YG; Na TY; Seo HW; Seong JK; Park CK; Shin YK; Lee MO Oncogene; 2008 May; 27(24):3405-13. PubMed ID: 18264140 [TBL] [Abstract][Full Text] [Related]
8. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer. Li K; Dias SJ; Rimando AM; Dhar S; Mizuno CS; Penman AD; Lewin JR; Levenson AS PLoS One; 2013; 8(3):e57542. PubMed ID: 23469203 [TBL] [Abstract][Full Text] [Related]
9. Andrographolide reduced VEGFA expression in hepatoma cancer cells by inactivating HIF-1α: The involvement of JNK and MTA1/HDCA. Shi L; Zhang G; Zheng Z; Lu B; Ji L Chem Biol Interact; 2017 Aug; 273():228-236. PubMed ID: 28651835 [TBL] [Abstract][Full Text] [Related]
10. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression. Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758 [TBL] [Abstract][Full Text] [Related]
11. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma. Buurman R; Sandbothe M; Schlegelberger B; Skawran B Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975 [TBL] [Abstract][Full Text] [Related]
12. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells. Yang Y; Qiu R; Zhao S; Shen L; Tang B; Weng Q; Xu Z; Zheng L; Chen W; Shu G; Wang Y; Zhao Z; Chen M; Ji J BMC Biol; 2022 Dec; 20(1):294. PubMed ID: 36575438 [TBL] [Abstract][Full Text] [Related]
13. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis. Deng L; Yang H; Tang J; Lin Z; Yin A; Gao Y; Wang X; Jiang R; Sun B J Exp Clin Cancer Res; 2015 Oct; 34():128. PubMed ID: 26503703 [TBL] [Abstract][Full Text] [Related]
16. The role of MTA1 gene expression in human hepatocellular carcinoma. Hamatsu T; Rikimaru T; Yamashita Y; Aishima S; Tanaka S; Shirabe K; Shimada M; Toh Y; Sugimachi K Oncol Rep; 2003; 10(3):599-604. PubMed ID: 12684630 [TBL] [Abstract][Full Text] [Related]
17. YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor. Dong S; Ma X; Wang Z; Han B; Zou H; Wu Z; Zang Y; Zhuang L Oncotarget; 2017 Jun; 8(25):40583-40593. PubMed ID: 28489564 [TBL] [Abstract][Full Text] [Related]
18. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity. Si W; Liu X; Wei R; Zhang Y; Zhao Y; Cui L; Hong T Cell Death Dis; 2019 Feb; 10(3):206. PubMed ID: 30814496 [TBL] [Abstract][Full Text] [Related]
19. Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma. Bian W; Zhang H; Tang M; Zhang S; Wang L; Liu L; Wang W Cell Physiol Biochem; 2018; 51(5):2065-2072. PubMed ID: 30522116 [TBL] [Abstract][Full Text] [Related]
20. Gd-Metallofullerenol Nanomaterial Suppresses Pancreatic Cancer Metastasis by Inhibiting the Interaction of Histone Deacetylase 1 and Metastasis-Associated Protein 1. Pan Y; Wang L; Kang SG; Lu Y; Yang Z; Huynh T; Chen C; Zhou R; Guo M; Zhao Y ACS Nano; 2015 Jul; 9(7):6826-36. PubMed ID: 26083726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]